Minimizing the risk of hemorrhagic stroke during anticoagulant therapy for atrial fibrillation

Management of major bleeding events in patients treated with rivaroxaban vs. warfarin: results from the ROCKET AF trial

(2014) J. P. Piccini et al.   EUROPEAN HEART JOURNAL

Efficacy and safety of apixaban compared with aspirin in patients who previously tried but failed treatment with vitamin K antagonists: results from the AVERROES trial

(2014) Michiel Coppens et al.   EUROPEAN HEART JOURNAL

Management of antithrombotic therapy in atrial fibrillation patients presenting with acute coronary syndrome and/or undergoing percutaneous coronary or valve interventions: a joint consensus document of the European Society of Cardiology Working Group on Thrombosis, European Heart Rhythm Association (EHRA), European Association of Percutaneous Cardiovascular Interventions (EAPCI) and European Association of Acute Cardiac Care (ACCA) endorsed by the Heart Rhythm Society (HRS) and Asia-Pacific Heart Rhythm Society (APHRS)

(2014) et al.   EUROPEAN HEART JOURNAL

2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation

(2014) Craig T. January et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Major Bleeding in Patients With Atrial Fibrillation Receiving Apixaban or Warfarin

(2014) Elaine M. Hylek et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Comparisons between Novel Oral Anticoagulants and Vitamin K Antagonists in Patients with CKD

(2014) Z. Harel et al.   JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY

New oral anticoagulants in patients with atrial fibrillation – Authors'reply

(2014) Christian T Ruff et al.   LANCET

APOE   variants increase risk of warfarin-related intracerebral hemorrhage

(2014) G. J. Falcone et al.   NEUROLOGY

Efficacy and Safety of Vitamin K-Antagonists (VKA) for Atrial Fibrillation in Non-Dialysis Dependent Chronic Kidney Disease

(2014) Judith Kooiman et al.   PLoS One

Reversal Agents in Development for the New Oral Anticoagulants

(2014) James Costin et al.   POSTGRADUATE MEDICINE

Intracranial Hemorrhage Mortality in Atrial Fibrillation Patients Treated With Dabigatran or Warfarin

(2014) Alvaro Alonso et al.   STROKE

Intracranial Hemorrhage Among Patients With Atrial Fibrillation Anticoagulated With Warfarin or Rivaroxaban

(2014) Graeme J. Hankey et al.   STROKE

Incidence of Symptomatic Hemorrhage in Patients With Lobar Microbleeds

(2014) Ellis S. van Etten et al.   STROKE

Atrial Fibrillation in CKD: Balancing the Risks and Benefits of Anticoagulation

(2013) Khai P. Ng et al.   AMERICAN JOURNAL OF KIDNEY DISEASES

New oral anticoagulants in elderly patients

(2013) Stefano Barco et al.   BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY

A Prospective Study of Estimated Glomerular Filtration Rate and Outcomes in Patients With Atrial Fibrillation

(2013) Amitava Banerjee et al.   CHEST

Percutaneous Left Atrial Appendage Closure for Stroke Prophylaxis in Patients With Atrial Fibrillation

(2013) Vivek Y. Reddy et al.   CIRCULATION

Management and Outcomes of Major Bleeding During Treatment With Dabigatran or Warfarin

(2013) Ammar Majeed et al.   CIRCULATION

European Heart Rhythm Association Practical Guide on the use of new oral anticoagulants in patients with non-valvular atrial fibrillation

(2013) Hein Heidbuchel et al.   EUROPACE

Left atrial appendage occlusion in atrial fibrillation after intracranial hemorrhage

(2013) S. Horstmann et al.   NEUROLOGY

Dabigatran versus Warfarin in Patients with Mechanical Heart Valves

(2013) John W. Eikelboom et al.   NEW ENGLAND JOURNAL OF MEDICINE

Edoxaban versus Warfarin in Patients with Atrial Fibrillation

(2013) Robert P. Giugliano et al.   NEW ENGLAND JOURNAL OF MEDICINE

Dabigatran and Postmarketing Reports of Bleeding

(2013) Mary Ross Southworth et al.   NEW ENGLAND JOURNAL OF MEDICINE

Educational Intervention Improves Anticoagulation Control in Atrial Fibrillation Patients: The TREAT Randomised Trial

(2013) Danielle E. Clarkesmith et al.   PLoS One

An Updated Definition of Stroke for the 21st Century

(2013) Ralph L. Sacco et al.   STROKE

Effect of warfarin on intracranial hemorrhage incidence and fatal outcomes

(2013) Daniel M. Witt et al.   THROMBOSIS RESEARCH

Cerebral Microbleeds and Macrobleeds: Should They Influence Our Recommendations for Antithrombotic Therapies?

(2013) Kellen E. Haley et al.   Current Cardiology Reports

Warfarin–Antibiotic Interactions in Older Adults of an Outpatient Anticoagulation Clinic

(2012) Parinaz K. Ghaswalla et al.   American Journal Geriatric Pharmacotherapy

Scores to Predict Major Bleeding Risk During Oral Anticoagulation Therapy: A Prospective Validation Study

(2012) Jacques Donzé et al.   AMERICAN JOURNAL OF MEDICINE

Antithrombotic Therapy for Atrial Fibrillation

(2012) John J. You et al.   CHEST

Net Clinical Benefit of Warfarin in Patients With Atrial Fibrillation

(2012) Leif Friberg et al.   CIRCULATION

Concomitant Use of Antiplatelet Therapy with Dabigatran or Warfarin in the Randomized Evaluation of Long-Term Anticoagulation Therapy (RE-LY) Trial

(2012) Antonio L. Dans et al.   CIRCULATION

Incidence and prevalence of atrial fibrillation: an analysis based on 8.3 million patients

(2012) T. Wilke et al.   EUROPACE

Evaluation of risk stratification schemes for ischaemic stroke and bleeding in 182 678 patients with atrial fibrillation: the Swedish Atrial Fibrillation cohort study

(2012) Leif Friberg et al.   EUROPEAN HEART JOURNAL

2012 focused update of the ESC Guidelines for the management of atrial fibrillation

(2012) et al.   EUROPEAN HEART JOURNAL

Performance of the HEMORR2HAGES, ATRIA, and HAS-BLED Bleeding Risk–Prediction Scores in Patients With Atrial Fibrillation Undergoing Anticoagulation

(2012) Stavros Apostolakis et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Phase III studies on novel oral anticoagulants for stroke prevention in atrial fibrillation: a look beyond the excellent results

(2012) V. PENGO et al.   JOURNAL OF THROMBOSIS AND HAEMOSTASIS

Heavy alcohol intake and intracerebral hemorrhage: Characteristics and effect on outcome

(2012) B. Casolla et al.   NEUROLOGY

A New Risk Scheme to Predict Warfarin-Associated Hemorrhage

(2011) Margaret C. Fang et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

The Coagulopathy of Chronic Liver Disease

(2011) Armando Tripodi et al.   NEW ENGLAND JOURNAL OF MEDICINE

Apixaban with Antiplatelet Therapy after Acute Coronary Syndrome

(2011) John H. Alexander et al.   NEW ENGLAND JOURNAL OF MEDICINE

Apixaban versus Warfarin in Patients with Atrial Fibrillation

(2011) Christopher B. Granger et al.   NEW ENGLAND JOURNAL OF MEDICINE

Rivaroxaban versus Warfarin in Nonvalvular Atrial Fibrillation

(2011) Manesh R. Patel et al.   NEW ENGLAND JOURNAL OF MEDICINE

Rivaroxaban in Patients with a Recent Acute Coronary Syndrome

(2011) Jessica L. Mega et al.   NEW ENGLAND JOURNAL OF MEDICINE

Risk factors of vitamin K antagonist overcoagulation

(2011) I. Marie et al.   QJM-AN INTERNATIONAL JOURNAL OF MEDICINE

Bleeding risk assessment and management in atrial fibrillation patients

(2011) Laurent Fauchier et al.   THROMBOSIS AND HAEMOSTASIS

Net clinical benefit of new oral anticoagulants (dabigatran, rivaroxaban, apixaban) versus no treatment in a ‘real world’ atrial fibrillation population: A modelling analysis based on a nationwide cohort study

(2011) Amitava Banerjee et al.   THROMBOSIS AND HAEMOSTASIS

Risk of Bleeding With Single, Dual, or Triple Therapy With Warfarin, Aspirin, and Clopidogrel in Patients With Atrial Fibrillation

(2010) Morten L. Hansen et al.   ARCHIVES OF INTERNAL MEDICINE

New Anticoagulants

(2010) John W. Eikelboom et al.   CIRCULATION

Guidelines for the management of atrial fibrillation: The Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC)

(2010) et al.   EUROPACE

Age as a Risk Factor for Stroke in Atrial Fibrillation Patients

(2010) Ricarda Marinigh et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Comparative Validation of a Novel Risk Score for Predicting Bleeding Risk in Anticoagulated Patients With Atrial Fibrillation

(2010) Gregory Y.H. Lip et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Efficacy and safety of dabigatran compared with warfarin at different levels of international normalised ratio control for stroke prevention in atrial fibrillation: an analysis of the RE-LY trial

(2010) Lars Wallentin et al.   LANCET

Risk factors for ischaemic and intracerebral haemorrhagic stroke in 22 countries (the INTERSTROKE study): a case-control study

(2010) Martin J O'Donnell et al.   LANCET

Incidence, case fatality, and functional outcome of intracerebral haemorrhage over time, according to age, sex, and ethnic origin: a systematic review and meta-analysis

(2010) Charlotte JJ van Asch et al.   LANCET NEUROLOGY

Increased Risk of Stroke Associated With Nonsteroidal Anti-Inflammatory Drugs

(2010) Chia-Hsuin Chang et al.   STROKE

Antithrombotic Drug Use, Cerebral Microbleeds, and Intracerebral Hemorrhage

(2010) Caroline E. Lovelock et al.   STROKE

Lower versus standard intensity oral anticoagulant therapy (OAT) in elderly warfarin-experienced patients with non-valvular atrial fibrillation

(2010) Umberto Cucchini et al.   THROMBOSIS AND HAEMOSTASIS

Dabigatran versus Warfarin in Patients with Atrial Fibrillation

(2009) Stuart J. Connolly et al.   NEW ENGLAND JOURNAL OF MEDICINE

Effect of Age on Stroke Prevention Therapy in Patients With Atrial Fibrillation

(2009) Carl van Walraven et al.   STROKE

Hypertension and cerebrovascular damage

(2008) Franco Veglio et al.   ATHEROSCLEROSIS

Nonaspirin Nonsteroidal Anti-inflammatory Drugs and Hemorrhagic Stroke Risk

(2008) Nam-Kyong Choi et al.   STROKE

Warfarin treatment in patients with atrial fibrillation: Observing outcomes associated with varying levels of INR control

(2008) Christopher Ll. Morgan et al.   THROMBOSIS RESEARCH

Don’t add aspirin for associated stable vascular disease in a patient with atrial fibrillation receiving anticoagulation

(2008) Gregory Y H Lip   BMJ-British Medical Journal